MedTrace Logo

Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ

NCT01132560 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-05-17

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in tissue samples from patients with ductal breast carcinoma in situ.

Conditions

Interventions

GENETIC

RNA analysis

GENETIC

gene expression analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Lawrence J. Solin, MD, FACR · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-05
Primary Completion
2010-04-05
Completion
2010-04-05

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01132560 on ClinicalTrials.gov